Industry
U.S. FDA issues four observations to Gland Pharma formulation facility near Hyderabad
The Hindu - Industry·24 Oct 2026
The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23
More news in Industry
Kilitch Drugs to divest Ethiopian arm for $14 million
Kobelco targets 8–10% topline growth as it launches three excavatorsCoforge net profit rises 56.5% as ‘record’ deal wins boost growth
Meta to delay new commercial terms criticised by publishers, advertisers
Govt extends duty-free raw sugar import window till Dec 31 to ease festive supplies
Kobelco targets 8–10% topline growth as it launches three excavatorsCoforge net profit rises 56.5% as ‘record’ deal wins boost growthMeta to delay new commercial terms criticised by publishers, advertisersGovt extends duty-free raw sugar import window till Dec 31 to ease festive supplies